Literature DB >> 25907065

Anticancer Activity of the Antimicrobial Peptide Scolopendrasin VII Derived from the Centipede, Scolopendra subspinipes mutilans.

Joon Ha Lee1, In-Woo Kim1, Sang-Hee Kim2, Mi-Ae Kim1, Eun-Young Yun1, Sung-Hee Nam1, Mi-Young Ahn1, Dongchul Kang3, Jae Sam Hwang1.   

Abstract

Previously, we performed de novo RNA sequencing of Scolopendra subspinipes mutilans using high-throughput sequencing technology and identified several antimicrobial peptide candidates. Among them, a cationic antimicrobial peptide, scolopendrasin VII, was selected based on its physicochemical properties, such as length, charge, and isoelectric point. Here, we assessed the anticancer activities of scolopendrasin VII against U937 and Jurkat leukemia cell lines. The results showed that scolopendrasin VII decreased the viability of the leukemia cells in MTS assays. Furthermore, flow cytometric analysis and acridine orange/ethidium bromide staining revealed that scolopendrasin VII induced necrosis in the leukemia cells. Scolopendrasin VII-induced necrosis was mediated by specific interaction with phosphatidylserine, which is enriched in the membrane of cancer cells. Taken together, these data indicated that scolopendrasin VII induced necrotic cell death in leukemia cells, probably through interaction with phosphatidylserine. The results provide a useful anticancer peptide candidate and an efficient strategy for new anticancer peptide development.

Entities:  

Keywords:  Anticancer activity; Antimicrobial peptide; Necrosis; Phosphatidylserine; Scolopendrasin VII

Mesh:

Substances:

Year:  2015        PMID: 25907065     DOI: 10.4014/jmb.1503.03091

Source DB:  PubMed          Journal:  J Microbiol Biotechnol        ISSN: 1017-7825            Impact factor:   2.351


  8 in total

1.  Antimicrobial peptide scolopendrasin VII, derived from the centipede Scolopendra subspinipes mutilans, stimulates macrophage chemotaxis via formyl peptide receptor 1.

Authors:  Yoo Jung Park; Ha Young Lee; Young Su Jung; Joon Seong Park; Jae Sam Hwang; Yoe-Sik Bae
Journal:  BMB Rep       Date:  2015-08       Impact factor: 4.778

Review 2.  Complementary and alternative medicine for treating amyotrophic lateral sclerosis: A narrative review.

Authors:  Mudan Cai; Eun Jin Yang
Journal:  Integr Med Res       Date:  2019-08-29

3.  Scorpion Venom Antimicrobial Peptides Induce Caspase-1 Dependant Pyroptotic Cell Death.

Authors:  Ranwa A Elrayess; Mahmoud E Mohallal; Yomn M Mobarak; Hala M Ebaid; Sarah Haywood-Small; Keith Miller; Peter N Strong; Mohamed A Abdel-Rahman
Journal:  Front Pharmacol       Date:  2022-01-10       Impact factor: 5.810

4.  Metabarcoding insights into the diet and trophic diversity of six declining farmland birds.

Authors:  Xabier Cabodevilla; François Mougeot; Gerard Bota; Santi Mañosa; Francesc Cuscó; Julen Martínez-García; Beatriz Arroyo; María J Madeira
Journal:  Sci Rep       Date:  2021-10-26       Impact factor: 4.379

5.  Retracted Article: Structural characterization of centipede oligopeptides and capability detection in human small cell lung carcinoma: inducing apoptosis.

Authors:  JingQuan Zhao; Jianmei Yang; Zerui Hao; Yulin An; Mingqiang Zhang; Jie Liu; Rongrong Ren; Dianjie Lin
Journal:  RSC Adv       Date:  2019-04-08       Impact factor: 4.036

Review 6.  Bioactive Peptides and Proteins from Centipede Venoms.

Authors:  Yalan Han; Peter Muiruri Kamau; Ren Lai; Lei Luo
Journal:  Molecules       Date:  2022-07-11       Impact factor: 4.927

Review 7.  Centipede venoms and their components: resources for potential therapeutic applications.

Authors:  Md Abdul Hakim; Shilong Yang; Ren Lai
Journal:  Toxins (Basel)       Date:  2015-11-17       Impact factor: 4.546

8.  Promotion of formyl peptide receptor 1-mediated neutrophil chemotactic migration by antimicrobial peptides isolated from the centipede Scolopendra subspinipes mutilans.

Authors:  Yoo Jung Park; Sung Kyun Lee; Young Su Jung; Mingyu Lee; Ha Young Lee; Sang Doo Kim; Joon Seong Park; JaeHyung Koo; Jae Sam Hwang; Yoe-Sik Bae
Journal:  BMB Rep       Date:  2016-09       Impact factor: 4.778

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.